Psoriatic arthritis (PsA) is a chronic, inflammatory, musculoskeletal, disabling disease, commonly associated with skin psoriasis, and estimated to affect up to 42% of the approximately 7.5 million people in the United States with psoriasis. There remains an ongoing challenge among clinicians to diagnose and treat patients, as well as to stay abreast of optimal treatment strategies. In this educational program, the latest biologic treatment recommendations are reviewed, as well as clinical trial results for novel emerging therapies. Clinician-patient communication examples are shared on how to engage patients in their management, along with best-practice, stepwise recommendations to achieve remission with minimal or low disease activity with the use of appropriate assessment and screening tools to improve overall outcomes in the PsA patient.
Please join Dr. Husni and Dr. Merola as they share their insights on how to make an early and accurate diagnosis for PsA and implement therapeutic strategies.
1.50 AMA PRA Category 1 Credits™.
1.50 ANCC Contact Hours
|Opens:||October 09, 2018|
|Expires:||October 08, 2019|
Primary Care Physicians
Other Healthcare Providers